Breast cancer radiotherapy: Frequently asked questions from ESTRO's multidisciplinary course
Birgitte Offersen,
Denmark;
Femke Froklage,
The Netherlands
In this session a variety of breast cancer subjects will be discussed. Firstly, targeted treatments and radiotherapy in breast cancer will be discussed with a particular focus on its potential synergistic effect and its potential safety concerns. Secondly, breast cancer radiotherapy for patients with connective tissue or genetic disorders will be presented, addressing radiation toxicity and secondary malignancy risk. Thirdly, examples of complicated treatment plans will be shown and different options to influence treatment plan will be given. Finally, the rationale for a nodal boost will be presented and nodal boost technique will be addressed.
3350
Symposium
Clinical